NCT06616311View on ClinicalTrials.gov

Efficacy of Radiofrequency Micro Needling for the Treatment of Melasma in Skin of Color.

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Melasma
Interventions
DEVICE

Radiofrequency microneedling

The target population is skin of color patients with melasma. Patients will receive 5 consecutive RFMN treatments over a period of 5 months.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

Benev Company, Inc.

INDUSTRY

lead

The Cleveland Clinic

OTHER

NCT06616311 - Efficacy of Radiofrequency Micro Needling for the Treatment of Melasma in Skin of Color. | Biotech Hunter | Biotech Hunter